Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Dec:123:106978.
doi: 10.1016/j.cct.2022.106978. Epub 2022 Oct 28.

The Preventing Alzheimer's with Cognitive Training (PACT) randomized clinical trial

Affiliations
Randomized Controlled Trial

The Preventing Alzheimer's with Cognitive Training (PACT) randomized clinical trial

Jody S Nicholson et al. Contemp Clin Trials. 2022 Dec.

Abstract

Background: To address the rising prevalence of Alzheimer's disease and related dementias, effective interventions that can be widely disseminated are warranted. The Preventing Alzheimer's with Cognitive Training study (PACT) investigates a commercially available computerized cognitive training program targeting improved Useful Field of View Training (UFOVT) performance. The primary goal is to test the effectiveness of UFOVT to reduce incidence of clinically defined mild cognitive impairment (MCI) or dementia with a secondary objective to examine if effects are moderated by plasma β-amyloid level or apolipoprotein E e4 (APOE e4) allele status.

Methods/design: This multisite study utilizes a randomized, controlled experimental design with blinded assessors and investigators. Individuals who are 65 years of age and older are recruited from the community. Eligible participants who demonstrate intact cognitive status (Montreal Cognitive Assessment score > 25) are randomized and asked to complete 45 sessions of either a commercially available computerized-cognitive training program (UFOVT) or computerized games across 2.5 years. After three years, participants are screened for cognitive decline. For those demonstrating decline or who are part of a random subsample, a comprehensive neuropsychological assessment is completed. Those who perform below a pre-specified level are asked to complete a clinical evaluation, including an MRI, to ascertain clinical diagnosis of normal cognition, MCI, or dementia. Participants are asked to provide blood samples for analyses of Alzheimer's disease related biomarkers.

Discussion: The PACT study addresses the rapidly increasing prevalence of dementia. Computerized cognitive training may provide a non-pharmaceutical option for reducing incidence of MCI or dementia to improve public health.

Registration: The PACT study is registered at http://Clinicaltrials.govNCT03848312.

Keywords: Aging; Alzheimer's disease; Blood biomarkers; Dementia; Useful field of view training.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Edwards worked between 1996 and 2005 as a consultant conducting related research studies for Visual Awareness, Inc., who owned the intellectual property surrounding the speed of processing training software. Posit Science now markets the newest version of the training program. Over an approximate three-month period in 2008, Dr. Edwards worked as a limited consultant to Posit Science, Inc. to analyze data and prepare a publication. Dr. Edwards worked as a consultant to Wilson, Sonsini, Goodrich & Rosati across an approximate three-month period between May–August of 2015.

References

    1. Cantarero-Prieto D, Leon PL, Blazquez-Fernandez C, Juan PS, Cobo CS. The economic cost of dementia: A systematic review. Dementia. 2020. Nov;19(8):2637–2657. - PubMed
    1. Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, et al. The public health impact of Alzheimer’s disease, 2000–2050: Potential implication of treatment advances. Annu Rev Public Health. 2002;23:213–231. - PubMed
    1. Davis MA, Chang C-H, Simonton S, Bynum JPW. Trends in US medicare decedents’ diagnosis of dementia from 2004 to 2017. JAMA Health Forum. 2022. Apr 1;3(4):e220346. - PMC - PubMed
    1. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020. Aug 8;396(10248):413–446. - PMC - PubMed
    1. National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Preventing Dementia and Cognitive Impairment. Preventing cognitive decline and dementia: A way forward. Downey A, Stroud C, Landis S, Leshner AI, editors. Washington (DC): National Academies Press (US); 2017. - PubMed

Publication types

Associated data